MedTrace Logo

Serial Testing To Assess Cognitive Function In Cancer

NCT06160700 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2024-06-10

No results posted yet for this study

Summary

The purpose of this study is to examine the effects of immunotherapy on cognitive function of cancer patients and follow them clinically over a period of six months with the Montreal cognitive assessment (MoCA) to assess changes in cognition.

Conditions

Interventions

BEHAVIORAL

Montreal Cognitive Assessment (MoCA)

MoCA is a method for evaluating cognition. This assessment will be conducted at baseline, month 3, and month 6.

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Nasser Hanna, MD · Indiana University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-20
Primary Completion
2024-03-12
Completion
2024-03-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06160700 on ClinicalTrials.gov